AMRX logo

Amneal Pharmaceuticals, Inc. (AMRX) Selling, general & administrative expenses

annual SGA:

$0.00-$429.68M(-100.00%)
December 31, 2024

Summary

  • As of today (September 18, 2025), AMRX annual SGA is $0.00, with the most recent change of -$429.68 million (-100.00%) on December 31, 2024.
  • During the last 3 years, AMRX annual SGA has fallen by -$365.50 million (-100.00%).
  • AMRX annual SGA is now -100.00% below its all-time high of $429.68 million, reached on December 31, 2023.

Performance

AMRX SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMRXincome statement metrics

quarterly SGA:

$0.00-$118.29M(-100.00%)
June 30, 2025

Summary

  • As of today (September 18, 2025), AMRX quarterly SGA is $0.00, with the most recent change of -$118.29 million (-100.00%) on June 30, 2025.
  • Over the past year, AMRX quarterly SGA has dropped by -$116.46 million (-100.00%).
  • AMRX quarterly SGA is now -100.00% below its all-time high of $118.69 million, reached on September 30, 2024.

Performance

AMRX quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMRXincome statement metrics

TTM SGA:

-$2.35B+$3.38M(+0.14%)
June 30, 2025

Summary

  • As of today (September 18, 2025), AMRX TTM SGA is -$2.35 billion, with the most recent change of +$3.38 million (+0.14%) on June 30, 2025.
  • Over the past year, AMRX TTM SGA has dropped by -$2.80 billion (-621.07%).
  • AMRX TTM SGA is now -204.65% below its all-time high of $2.25 billion.

Performance

AMRX TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMRXincome statement metrics

Selling, general & administrative expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

AMRX Selling, general & administrative expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-100.0%-100.0%-621.1%
3 y3 years-100.0%-100.0%-708.8%
5 y5 years-100.0%-100.0%-891.9%

AMRX Selling, general & administrative expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-100.0%at low-100.0%at low-92.1%+0.1%
5 y5-year-100.0%at low-100.0%at low-115.6%+0.1%
alltimeall time-100.0%at low-100.0%at low-204.7%+0.1%

AMRX Selling, general & administrative expenses History

DateAnnualQuarterlyTTM
Jun 2025
-
$0.00(-100.0%)
$236.98M(-33.0%)
Mar 2025
-
$118.29M(>+9900.0%)
$353.44M(+1.6%)
Dec 2024
$0.00(-100.0%)
$0.00(-100.0%)
$347.75M(-23.9%)
Sep 2024
-
$118.69M(+1.9%)
$456.75M(+1.3%)
Jun 2024
-
$116.46M(+3.4%)
$451.07M(+2.5%)
Mar 2024
-
$112.59M(+3.3%)
$440.17M(+2.4%)
Dec 2023
$429.68M(+7.5%)
$109.00M(-3.5%)
$429.68M(+1.6%)
Sep 2023
-
$113.01M(+7.0%)
$422.83M(+3.2%)
Jun 2023
-
$105.57M(+3.4%)
$409.89M(+1.7%)
Mar 2023
-
$102.10M(-0.1%)
$403.13M(+0.9%)
Dec 2022
$399.70M(+9.4%)
$102.16M(+2.1%)
$399.70M(+1.2%)
Sep 2022
-
$100.07M(+1.3%)
$394.77M(+2.2%)
Jun 2022
-
$98.81M(+0.1%)
$386.09M(+3.4%)
Mar 2022
-
$98.67M(+1.5%)
$373.44M(+2.2%)
Dec 2021
$365.50M(+11.9%)
$97.22M(+6.4%)
$365.50M(+3.6%)
Sep 2021
-
$91.40M(+6.1%)
$352.97M(+2.4%)
Jun 2021
-
$86.16M(-5.0%)
$344.69M(+1.5%)
Mar 2021
-
$90.73M(+7.1%)
$339.48M(+3.9%)
Dec 2020
$326.73M(+12.8%)
$84.69M(+1.9%)
$326.73M(+3.4%)
Sep 2020
-
$83.12M(+2.7%)
$316.12M(+6.5%)
Jun 2020
-
$80.94M(+3.8%)
$296.80M(+4.8%)
Mar 2020
-
$77.98M(+5.3%)
$283.14M(-2.2%)
Dec 2019
$289.60M(+25.7%)
$74.08M(+16.1%)
$289.60M(-0.1%)
Sep 2019
-
$63.80M(-5.2%)
$289.75M(-4.7%)
Jun 2019
-
$67.28M(-20.3%)
$304.03M(+4.9%)
Mar 2019
-
$84.44M(+13.7%)
$289.75M(+25.7%)
Dec 2018
$230.44M(+111.3%)
$74.24M(-4.9%)
$230.44M(+25.8%)
Sep 2018
-
$78.08M(+47.3%)
$183.16M(+38.2%)
Jun 2018
-
$53.00M(+111.0%)
$132.53M(+24.5%)
Mar 2018
-
$25.12M(-6.8%)
$106.47M(+30.9%)
Dec 2017
$109.05M(-46.0%)
$26.97M(-1.7%)
$81.34M(-27.3%)
Sep 2017
-
$27.44M(+1.9%)
$111.96M(-19.8%)
Jun 2017
-
$26.94M(>+9900.0%)
$139.56M(-11.4%)
Mar 2017
-
$0.00(-100.0%)
$157.53M(-21.9%)
Dec 2016
$201.83M(+0.3%)
-
-
Dec 2016
-
$57.59M(+4.6%)
$201.83M(+0.5%)
Sep 2016
-
$55.04M(+22.6%)
$200.75M(+4.5%)
Jun 2016
-
$44.91M(+1.4%)
$192.02M(-1.7%)
Mar 2016
-
$44.30M(-21.6%)
$195.43M(-2.9%)
Dec 2015
$201.29M(+44.4%)
$56.51M(+22.0%)
$201.29M(+7.6%)
Sep 2015
-
$46.31M(-4.1%)
$186.98M(+4.1%)
Jun 2015
-
$48.31M(-3.7%)
$179.56M(+9.4%)
Mar 2015
-
$50.16M(+18.8%)
$164.07M(+17.7%)
Dec 2014
$139.39M(+15.9%)
$42.21M(+8.5%)
$139.39M(+10.2%)
Sep 2014
-
$38.89M(+18.5%)
$126.51M(+9.4%)
Jun 2014
-
$32.82M(+28.8%)
$115.59M(-0.4%)
Mar 2014
-
$25.48M(-13.1%)
$116.05M(-3.5%)
Dec 2013
$120.29M(+10.9%)
$29.33M(+4.9%)
$120.29M(-3.3%)
Sep 2013
-
$27.97M(-15.9%)
$124.40M(-0.8%)
Jun 2013
-
$33.27M(+12.0%)
$125.36M(+7.2%)
Mar 2013
-
$29.72M(-11.1%)
$116.95M(+7.8%)
Dec 2012
$108.47M
$33.44M(+15.6%)
$108.47M(+14.1%)
Sep 2012
-
$28.93M(+16.3%)
$95.10M(+15.3%)
DateAnnualQuarterlyTTM
Jun 2012
-
$24.87M(+17.1%)
$82.49M(+12.8%)
Mar 2012
-
$21.23M(+5.8%)
$73.13M(+6.8%)
Dec 2011
$68.48M(+28.4%)
$20.07M(+23.0%)
$68.48M(+6.0%)
Sep 2011
-
$16.32M(+5.2%)
$64.60M(+6.1%)
Jun 2011
-
$15.51M(-6.5%)
$60.91M(+7.2%)
Mar 2011
-
$16.58M(+2.4%)
$56.85M(+7.8%)
Dec 2010
$53.33M(+34.3%)
$16.19M(+28.2%)
$52.75M(+44.3%)
Sep 2010
-
$12.63M(+10.4%)
$36.56M(+8.3%)
Jun 2010
-
$11.44M(-8.3%)
$33.77M(+4.3%)
Mar 2010
-
$12.48M(>+9900.0%)
$32.36M(+3.3%)
Dec 2009
$39.71M(-17.1%)
$0.00(-100.0%)
$31.33M(-26.4%)
Sep 2009
-
$9.84M(-2.0%)
$42.56M(-10.1%)
Jun 2009
-
$10.04M(-12.4%)
$47.36M(-4.0%)
Mar 2009
-
$11.46M(+2.0%)
$49.34M(+2.3%)
Dec 2008
$47.90M(+21.0%)
$11.23M(-23.3%)
$48.25M(-0.9%)
Sep 2008
-
$14.64M(+21.8%)
$48.70M(+12.7%)
Jun 2008
-
$12.02M(+16.0%)
$43.22M(+6.7%)
Mar 2008
-
$10.36M(-11.2%)
$40.50M(+2.3%)
Dec 2007
$39.57M(+22.3%)
$11.68M(+27.5%)
$39.57M(+5.8%)
Sep 2007
-
$9.16M(-1.5%)
$37.39M(+6.8%)
Jun 2007
-
$9.30M(-1.4%)
$35.00M(+1.5%)
Mar 2007
-
$9.43M(-0.7%)
$34.49M(+6.6%)
Dec 2006
$32.36M(+25.6%)
$9.50M(+40.4%)
$32.36M(+41.5%)
Sep 2006
-
$6.77M(-23.0%)
$22.86M(+42.0%)
Jun 2006
-
$8.79M(+20.3%)
$16.10M(+120.3%)
Mar 2006
-
$7.31M(+74.1%)
$7.31M(-53.4%)
Dec 2005
$25.76M(+120.7%)
-
-
Sep 2004
-
$4.20M(+9.6%)
$15.70M(+9.3%)
Jun 2004
-
$3.83M(-6.1%)
$14.37M(+10.0%)
Mar 2004
-
$4.08M(+13.4%)
$13.06M(+11.9%)
Dec 2003
$11.67M(+3.9%)
$3.59M(+25.4%)
$11.67M(+44.5%)
Sep 2003
-
$2.87M(+13.7%)
$8.08M(+1.1%)
Jun 2003
-
$2.52M(-6.3%)
$7.99M(-0.8%)
Mar 2003
-
$2.69M(>+9900.0%)
$8.06M(-0.5%)
Dec 2002
$11.23M(+48.7%)
$0.00(-100.0%)
$8.10M(0.0%)
Sep 2002
-
$2.78M(+7.6%)
$8.10M(+12.3%)
Jun 2002
-
$2.58M(-5.4%)
$7.21M(+7.7%)
Mar 2002
-
$2.73M(>+9900.0%)
$6.69M(+22.5%)
Dec 2001
$7.56M(+16.1%)
$0.00(-100.0%)
$5.47M(0.0%)
Sep 2001
-
$1.89M(-8.6%)
$5.47M(+52.9%)
Jun 2001
-
$2.07M(+37.6%)
$3.57M(+137.6%)
Mar 2001
-
$1.50M(>+9900.0%)
$1.50M(>+9900.0%)
Dec 2000
$6.51M(>+9900.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2000
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2000
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2000
-
$0.00(0.0%)
$0.00(0.0%)
Dec 1999
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 1999
-
$0.00(0.0%)
$0.00(0.0%)
Jun 1999
-
$0.00(0.0%)
$0.00(0.0%)
Mar 1999
-
$0.00(0.0%)
$0.00(0.0%)
Dec 1998
$0.00
$0.00(0.0%)
$0.00(0.0%)
Sep 1998
-
$0.00(0.0%)
$0.00(0.0%)
Jun 1998
-
$0.00(0.0%)
$0.00(0.0%)
Mar 1998
-
$0.00
$0.00

FAQ

  • What is Amneal Pharmaceuticals, Inc. annual SGA?
  • What is the all time high annual SGA for Amneal Pharmaceuticals, Inc.?
  • What is Amneal Pharmaceuticals, Inc. annual SGA year-on-year change?
  • What is Amneal Pharmaceuticals, Inc. quarterly SGA?
  • What is the all time high quarterly SGA for Amneal Pharmaceuticals, Inc.?
  • What is Amneal Pharmaceuticals, Inc. quarterly SGA year-on-year change?
  • What is Amneal Pharmaceuticals, Inc. TTM SGA?
  • What is the all time high TTM SGA for Amneal Pharmaceuticals, Inc.?
  • What is Amneal Pharmaceuticals, Inc. TTM SGA year-on-year change?

What is Amneal Pharmaceuticals, Inc. annual SGA?

The current annual SGA of AMRX is $0.00

What is the all time high annual SGA for Amneal Pharmaceuticals, Inc.?

Amneal Pharmaceuticals, Inc. all-time high annual SGA is $429.68M

What is Amneal Pharmaceuticals, Inc. annual SGA year-on-year change?

Over the past year, AMRX annual SGA has changed by -$429.68M (-100.00%)

What is Amneal Pharmaceuticals, Inc. quarterly SGA?

The current quarterly SGA of AMRX is $0.00

What is the all time high quarterly SGA for Amneal Pharmaceuticals, Inc.?

Amneal Pharmaceuticals, Inc. all-time high quarterly SGA is $118.69M

What is Amneal Pharmaceuticals, Inc. quarterly SGA year-on-year change?

Over the past year, AMRX quarterly SGA has changed by -$116.46M (-100.00%)

What is Amneal Pharmaceuticals, Inc. TTM SGA?

The current TTM SGA of AMRX is -$2.35B

What is the all time high TTM SGA for Amneal Pharmaceuticals, Inc.?

Amneal Pharmaceuticals, Inc. all-time high TTM SGA is $2.25B

What is Amneal Pharmaceuticals, Inc. TTM SGA year-on-year change?

Over the past year, AMRX TTM SGA has changed by -$2.80B (-621.07%)
On this page